Company Search:
Advanced Search
Sponsored Links
Seattle Genetics, Inc. Company Snapshot
Seattle Genetics, Inc. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Seattle Genetics with three other companies in this sector in the United States: BIO-TECHNE Corp (2015 sales of $452.25 million of which 72% was Biotechnology), Halozyme Therapeutics, Inc. ($135.06 million of which 100% was Biopharmaceutical), and Acorda Therapeutics, Inc. ($492.66 million of which 100% was Zanaflex).

Sales Analysis. During the year ended December of 2015, sales at Seattle Genetics were $336.80 million. This is an increase of 17.5% versus 2014, when the company's sales were $286.76 million. This was the fourth straight year of sales growth at Seattle Genetics.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Seattle Genetics, Inc.
  Stock Performance Chart for Seattle Genetics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2016): 66.70
(Figures in U.S. Dollars)
1 Week -7.2%   13 Weeks 18.6%  
4 Weeks 49.0%   52 Weeks 66.5%  
Seattle Genetics, Inc. Key Data:
  Ticker: SGEN Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 336,802,000
(Year Ending Jan 2016).
Employees: 759
  Currency: U.S. Dollars Market Cap: 9,438,383,500
  Fiscal Yr Ends: December Shares Outstanding: 141,505,000
  Share Type: Common Closely Held Shares: 1,159,201
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.